Annual Report 2021 22 Our product and service offering sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids, and cochlear implants. our product brands – phonak, unitron, sennheiser (under license), and advanced bionics – create compelling new. Sonova entered the 2022 23 financial year with an ambitious growth plan, taking advantage of its strong market position. performance did not fully meet our initial expectations, due to unforeseen challenges.
Sonova Annual Report 2021 22 Sonova entered the 2022 23 financial year with an ambitious growth plan, taking ad vantage of its strong market position. per formance did not fully meet our initial expec tations, due to unforeseen challenges. 7 sonova annual report 2022 23 our product and service offering. our product and service offering sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids, and cochlear implants. Sonova saw more robust momentum in the second half and ended the year on a positive note. we continued to implement our strategy, systematically and comprehensively: advancing our product portfolio, extending direct engagement with our consumers, and delivering continuous im provement in our operational and commercial execution. We entered the emerging over the counter hearing aid market in the us with all day clear, a new self fitting hearing aid sold under the sennheiser brand. and we significantly extended the capabilities of our cochlear implants portfolio with our unique remote programming solution. basic audiological research continues to drive our innovation.
Sonova Annual Report 2021 22 Sonova saw more robust momentum in the second half and ended the year on a positive note. we continued to implement our strategy, systematically and comprehensively: advancing our product portfolio, extending direct engagement with our consumers, and delivering continuous im provement in our operational and commercial execution. We entered the emerging over the counter hearing aid market in the us with all day clear, a new self fitting hearing aid sold under the sennheiser brand. and we significantly extended the capabilities of our cochlear implants portfolio with our unique remote programming solution. basic audiological research continues to drive our innovation. Explore millions of resources from scholarly journals, books, newspapers, videos and more, on the proquest platform. Sonova group sales reached chf 3,738.4 million in the 2022 23 financial year, an increase of 14.6% in local currencies and 11.1% in swiss francs. sales were supported by the successful launch of the phonak lumity platform in august 2022, as well as by price increases implemented to offset inflationary pressures. Sonova group sales reached chf 3,738.4 million in the 2022 23 financial year, an increase of 14.6% in local currencies and 11.1% in swiss francs. sales were supported by the successful launch of the phonak lumity platform in august 2022, as well as by price increases implemented to offset inflationary pressures.
Comments are closed.